Literature DB >> 32016011

Therapeutic potential of microRNAs in the regulation of cancer energy metabolism.

Misa Yamamoto1, Kenjiro Sawada1, Tadashi Kimura1.   

Abstract

Entities:  

Year:  2019        PMID： 32016011      PMCID： PMC6976493          DOI： 10.21037/atm.2019.11.56

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  21 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  Emergence of MicroRNAs as Key Players in Cancer Cell Metabolism.

Authors:  Sugarniya Subramaniam; Varinder Jeet; Judith A Clements; Jennifer H Gunter; Jyotsna Batra
Journal:  Clin Chem       Date:  2019-05-17       Impact factor: 8.327

3.  miR-450a Acts as a Tumor Suppressor in Ovarian Cancer by Regulating Energy Metabolism.

Authors:  Bruna Rodrigues Muys; Josane F Sousa; Jessica Rodrigues Plaça; Luíza Ferreira de Araújo; Aishe A Sarshad; Dimitrios G Anastasakis; Xiantao Wang; Xiao Ling Li; Greice Andreotti de Molfetta; Anelisa Ramão; Ashish Lal; Daniel Onofre Vidal; Markus Hafner; Wilson A Silva
Journal:  Cancer Res       Date:  2019-05-17       Impact factor: 12.701

Review 4.  OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer.

Authors:  Alexander A Svoronos; Donald M Engelman; Frank J Slack
Journal:  Cancer Res       Date:  2016-06-20       Impact factor: 12.701

Review 5.  Treating cancer with microRNA replacement therapy: A literature review.

Authors:  Nayer Hosseinahli; Mahyar Aghapour; Pascal H G Duijf; Behzad Baradaran
Journal:  J Cell Physiol       Date:  2018-03-09       Impact factor: 6.384

6.  Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.

Authors:  Lin Zhang; Stefano Volinia; Tomas Bonome; George Adrian Calin; Joel Greshock; Nuo Yang; Chang-Gong Liu; Antonis Giannakakis; Pangiotis Alexiou; Kosei Hasegawa; Cameron N Johnstone; Molly S Megraw; Sarah Adams; Heini Lassus; Jia Huang; Sippy Kaur; Shun Liang; Praveen Sethupathy; Arto Leminen; Victor A Simossis; Raphael Sandaltzopoulos; Yoshio Naomoto; Dionyssios Katsaros; Phyllis A Gimotty; Angela DeMichele; Qihong Huang; Ralf Bützow; Anil K Rustgi; Barbara L Weber; Michael J Birrer; Artemis G Hatzigeorgiou; Carlo M Croce; George Coukos
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

Review 7.  Targeting mitochondria in cancer: current concepts and immunotherapy approaches.

Authors:  Sergey Pustylnikov; Francesca Costabile; Silvia Beghi; Andrea Facciabene
Journal:  Transl Res       Date:  2018-07-31       Impact factor: 7.012

8.  Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.

Authors:  Jian Wang; Hui Wang; Aifen Liu; Changge Fang; Jianguo Hao; Zhenghui Wang
Journal:  Oncotarget       Date:  2015-08-14

Review 9.  Cancer cell metabolism: implications for therapeutic targets.

Authors:  Miran Jang; Sung Soo Kim; Jinhwa Lee
Journal:  Exp Mol Med       Date:  2013-10-04       Impact factor: 8.718

Review 10.  Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy.

Authors:  Christos E Zois; Adrian L Harris
Journal:  J Mol Med (Berl)       Date:  2016-02-17       Impact factor: 4.599
View more
  1 in total

1.  miR-328-3p overexpression attenuates the malignant proliferation and invasion of liver cancer via targeting Endoplasmic Reticulum Metallo Protease 1 to inhibit AKT phosphorylation.

Authors:  Hua Lu; Jiali Hu; Jianping Li; Weifeng Lu; Xiaofan Deng; Xu Wang
Journal:  Ann Transl Med       Date:  2020-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.